Clinical Trial Update: Gut Microbiota Transplantation in Systemic Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on gut microbiota transplantation for systemic sclerosis (scleroderma) across Phase 1 and Phase 2, status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scleroderma
• Systemic Sclerosis

Snippet

Sponsor: Oslo University Hospital | Conditions: Scleroderma, Systemic | Phase 1, Phase 2 | Status: COMPLETED